Although sequencing is required for a definitive LS diagnosis, identifying LS in MMR‐deficient patients offers important benefits, such as early screening for colorectal and other associated cancers, as well as proactive surveillance for blood relatives. The gene discussed is MRC1; the disease is Leigh syndrome.